Draft:Aaron Fischman

[[Category:AfC submissions by date/<0028Mon, 23 Feb 2026 14:51:00 +0000202622 2026-02-23T14:51:00+00:00Mondaypm0000=error>EpMon, 23 Feb 2026 14:51:00 +0000UTC00005120262 UTCMon, 23 Feb 2026 14:51:00 +0000Mon, 23 Feb 2026 14:51:00 +00002026Mon, 23 Feb 2026 14:51:00 +0000: 17718582602Mon, 23 Feb 2026 14:51:00 +0000UTC2026-02-23T14:51:00+00:002026225153UTC23 pu22026-02-23T14:51:00+00:0028upm285120262 2026-02-23T14:51:00+00:0002pmMon, 23 Feb 2026 14:51:00 +0000pm2026-02-23T14:51:00+00:0028UTCMon, 23 Feb 2026 14:51:00 +0000 &qu202628;:&qu202628;.</0028Mon, 23 Feb 2026 14:51:00 +0000202622>February 2026|Aaron Fischman]]

Aaron M. Fischman (born c. 1978) is an American interventional radiologist and professor at the Icahn School of Medicine at Mount Sinai in New York City. He is known for pioneering the transradial (wrist-access) technique for prostate artery embolization (PAE) and for developing novel approaches using liquid embolic agents that reduce procedure time and radiation dose. He serves as Program Director of the Interventional Radiology residency training program for the Mount Sinai Health System and has authored over 130 peer-reviewed publications.

Early life and education

Fischman received a Bachelor of Arts in Economics from Dartmouth College. He obtained his MD from the State University of New York Upstate Medical University in 2004. He completed his residency in diagnostic radiology at the Icahn School of Medicine at Mount Sinai, where he served as Chief Resident, followed by a fellowship in Vascular and Interventional Radiology at the same institution in 2010.[1]

Career

Fischman joined the Division of Vascular and Interventional Radiology at Mount Sinai in 2010. He holds the rank of Professor of Diagnostic, Molecular and Interventional Radiology, Urology, and Surgery at the Icahn School of Medicine at Mount Sinai.[1] He is board-certified by the American Board of Radiology in both Diagnostic Radiology and Vascular and Interventional Radiology.[2]

He is a Fellow of the Society of Interventional Radiology (FSIR), a Fellow of the Cardiovascular and Interventional Radiological Society of Europe (FCIRSE), and a Fellow of the Society of Vascular Medicine (FSVM). He is also a member of the Alpha Omega Alpha Medical Honor Society, the Radiological Society of North America, the American Roentgen Ray Society, and the American College of Phlebology.[1]

Program Director, IR Residency

Fischman serves as Program Director of the nationally recognized Interventional Radiology residency training program for the entire Mount Sinai Health System, overseeing the training of the next generation of interventional radiologists.[1]

Prostate artery embolization

Fischman is recognized internationally as a pioneer of prostate artery embolization (PAE), a minimally invasive procedure used to treat benign prostatic hyperplasia (BPH). He was among the first to systematically perform and teach PAE using transradial access — an approach in which the catheter is introduced through the wrist rather than the groin, reducing recovery time and improving patient comfort.[3]

He developed novel PAE techniques using n-butyl cyanoacrylate (n-BCA) liquid embolic agents, which have been shown to reduce fluoroscopy time and radiation dose compared to conventional microsphere-based approaches.[4]

Fischman was principal investigator of the BEST Trial (Benign prostatic hyperplasia Embolization versus Standard TURP), a prospective randomized clinical trial comparing PAE to transurethral resection of the prostate (TURP), which remains the surgical gold standard for BPH. The trial enrolled 114 patients and demonstrated that PAE produced comparable symptomatic improvement to TURP at 24 months, with a significantly lower rate of adverse events.[5]

He also served as principal investigator of the BEAT Obesity Trial, a clinical trial investigating bariatric arterial embolization as a minimally invasive approach to weight loss without surgery.[1]

In 2024, Fischman was among the expert panelists contributing to a major roundtable on optimizing PAE outcomes published in Endovascular Today, discussing the impact of updated American Urological Association guidelines, long-term data, and emerging technologies including AI-assisted vessel mapping.[6]

Other clinical contributions

Beyond PAE, Fischman's clinical practice encompasses a broad range of interventional procedures including:

Education and international training

Fischman trains interventional radiologists from across the United States, Europe, and Asia in transradial techniques and PAE. He is the founder of the TREAT iR (Transradial Embolization and Arterial Therapy in Interventional Radiology) symposium, a live-case educational program for advanced IR practitioners.[8]

He contributed to the Society of Interventional Radiology Quality Improvement Standards on Radial Artery Access[9] and has submitted formal comment to the Nuclear Regulatory Commission on behalf of interventional radiologists regarding yttrium-90 device authorization pathways.[10]

SIR Consensus Panel

Fischman participated in the Society of Interventional Radiology Consensus Panel on the Development of a Research Agenda in Prostate Artery Embolization, contributing to the multisociety position statement on PAE for BPH endorsed by the SIR, CIRSE, and multiple international IR societies.[9]

Recognition

Fischman has been named a Castle Connolly Top Doctor for eight consecutive years, a peer-nominated distinction recognizing physicians judged by their peers to be among the best in their field.[1]

He received the Harold A. Mitty Excellence in Education award from Mount Sinai, recognizing his contributions to radiology education.[1]

Selected publications

Fischman has authored over 130 peer-reviewed publications. Selected works include:

  • Noor A, Fischman AM. "Prostate Artery Embolization as a New Treatment for Benign Prostate Hyperplasia: Contemporary Status in 2016." Current Urology Reports. 2016;17(7):51. doi:10.1007/s11934-016-0608-0 PMID 27146488[11]
  • Rumball IP, ..., Fischman AM. "Comparison of 24-Month Clinical Outcomes after Prostatic Artery Embolization in Prostate Glands Larger versus Smaller than 80 mL: A Systematic Review." Journal of Vascular and Interventional Radiology. 2023;34(4). doi:10.1016/j.jvir.2022.11.022[12]
  • Garcia-Reyes K, Fischman AM. "Development of Research Agenda in Prostate Artery Embolization: Summary of Society of Interventional Radiology Consensus Panel." Journal of Vascular and Interventional Radiology.[9]
  • Sher A, Ranade M, Kim E, ..., Fischman AM, et al. "Single-System Experience With Outpatient Transradial Uterine Artery Embolization: Safety, Feasibility, Outcomes, and Early Rates of Return." Journal of Vascular and Interventional Radiology.[9]

Full publication list available via PubMed [1] and the Mount Sinai Scholars portal [2].

References

  1. ^ a b c d e f g "Aaron Fischman, MD — Faculty Profile". Mount Sinai Health System. Retrieved 2026-02-23.
  2. ^ "Dr. Aaron Fischman, MD". Healthgrades. Retrieved 2026-02-23.
  3. ^ "At the Nexus of Image Quality and Dose". Endovascular Today. April 2025. Retrieved 2026-02-23.
  4. ^ Williams, Thomas; Marquis, Alessandro; Unger, Pamela; Yeisley, Christopher D.; Knauer, Cynthia J.; Fischman, Aaron M.; Siegel, David N.; Rastinehad, Ardeshir R. (November 2025). "Glue (n-Butyl Cyanoacrylate) for Prostate Artery Embolization: Development of a Glue Penetration Score and Association with Clinical Outcomes". Journal of Vascular and Interventional Radiology. doi:10.1016/j.jvir.2025.01.001.
  5. ^ Carnevale, Francisco Cesar. "Benign Prostatic Hyperplasia: Prostatic Arterial Embolization versus Transurethral Resection of the Prostate—A Prospective, Randomized, and Controlled Clinical Trial". Radiology. Retrieved 2026-02-23.
  6. ^ "Optimizing Prostatic Artery Embolization Outcomes". Endovascular Today. February 2024. Retrieved 2026-02-23.
  7. ^ "SIR: New Way of Access Providing Comfort in Uterine Fibroid Treatment". EurekAlert! / Society of Interventional Radiology. Retrieved 2026-02-23.
  8. ^ "TREAT iR Symposium". Retrieved 2026-02-23.
  9. ^ a b c d "Dr. Aaron M. Fischman, MD". US News & World Report Health. Retrieved 2026-02-23.
  10. ^ "Comment of Aaron M. Fischman, MD on NRC Proposed Changes to Y-90 Licensing Guidance" (PDF). U.S. Nuclear Regulatory Commission. Retrieved 2026-02-23.
  11. ^ Noor, A.; Fischman, A.M. (July 2016). "Prostate Artery Embolization as a New Treatment for Benign Prostate Hyperplasia: Contemporary Status in 2016". Current Urology Reports. 17 (7): 51. doi:10.1007/s11934-016-0608-0. PMID 27146488.
  12. ^ Rumball, Ian P.; Fischman, Aaron M. (April 2023). "Comparison of 24-Month Clinical Outcomes after Prostatic Artery Embolization in Prostate Glands Larger versus Smaller than 80 mL: A Systematic Review". Journal of Vascular and Interventional Radiology. 34 (4). doi:10.1016/j.jvir.2022.11.022.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.